The information on this page is based on a number of underlying datasets, most of which are updated monthly. We maintain an update schedule which explains which version of each dataset we are currently relying on.
41 CARRFIELD is a very small flat of 48m², built sometime between 2007 and 2011, which could now be worth an estimated £121,836. It was last sold for £74,000 in August 2010, which was around 1% below the average August 2010 flat price in the Tameside local authority area. The most recent EPC inspection was April 2026, where the current energy rating was B, and the potential energy rating was B.
Land registry data shows one sale for 41 CARRFIELD since 1st January 1995. The below table shows the price paid for the one sale, along with the average flat price in the Tameside local authority area for the corresponding sale date. The average price is sourced from the Office for National Statistics' House Price Index (HPI).
| Date | Price | HPI Price | Variation from HPI |
|---|---|---|---|
2010 27 AUG | £74,000 | £74,878 | 1% below HPI |
41 CARRFIELD might now be worth an estimated £121,836.
This is based on house price inflation of 64.6%, between August 2010 and May 2026, for flats, in the Tameside local authority area, as calculated by the Office for National Statistics and published in their UK House Price Index (HPI).
The 64.6% inflationary increase is applied to the most recent sale price for 41 CARRFIELD of £74,000 on 27th August 2010. For the value to have increased from £74,000 to £121,836 over the sixteen years and three months to May 2026, the following assumptions must hold true:
41 CARRFIELD is 48m² according to the EPC inspection conducted in April 2026. This puts it in the smallest 20% of flats in Hyde, based on EPC data. 20% of flats are smaller than 41 CARRFIELD, and 79% of flats are larger. Note that EPC data is not available for all properties in Hyde.
41 CARRFIELD sits on a plot of roughly 0.848 of an acre, or 3,430m².
41 CARRFIELD is located in HYDE, in the SK14 postcode district.
Most recent sales first: